Feedback / Questions
MK-1045 - Merck (MSD)
https://www.cancernetwork.com/view/novel-treatment-displays-tolerability-in-relapsed-refractory-b-cell-all
Dec 9, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next